selected scholarly activity
-
journal articles
- Reducing medical cannabis use risk among Veterans: A descriptive study.. Harm Reduction Journal. 22:9. 2025
- Views on and experiences with medicinal cannabis among Canadian veterans who live with pain: A qualitative study. Canadian Journal of Pain. 7:2232838. 2023
- Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction. Journal of Pharmacy Practice. 35:322-326. 2022
- Assessing the impact of a cannabis course on pharmacy students’ understanding, beliefs and preparedness regarding medical and recreational cannabis. Canadian Pharmacists Journal. 155:50-59. 2022
- Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination. PLoS ONE. 15:e0234176-e0234176. 2020
- Mandatory pharmacist-led education session for patients seeking medical cannabis. Pharmacy Practice. 18:2088-2088. 2020
- Pertuzumab and trastuzumab infusion related cytokine release syndrome in a chemotherapy naive patient with metastatic breast cancer. Breast Journal. 24:383-384. 2018
- Cannabis Use Characteristics and PTSD-Related Outcomes Among Canadian Veterans With Chronic Pain. Journal of Veterans Studies. 11.
- Medical Cannabis Induced Acute Pancreatitis and Hyperemesis Syndrome in a Patient with Complex Regional Pain Syndrome. Canadian Journal of Pain.